We are live on ! Find out more
BIOA

BioAmber Inc.
BIOA

Delisted

BIOA was delisted on the 8th of February, 2018.

Back to rankings

33 hedge funds and large institutions have $63.7M invested in BioAmber Inc. in 2014 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 2

71% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 7

22% more funds holding

Funds holding: 27 → 33 (+6)

16% less capital invested

Capital invested by funds: $76M → $63.7M (-$12.3M)

Holders
33
Holders Change
+6
Holders Change %
+22.22%
% of All Funds
0.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
12
Reduced
7
Closed
2
Calls
$860K
Puts
–
Net Calls
+$860K
Net Calls Change
-$177K

Top Buyers

Rank Fund Capital Flow
1
RA
Royce & Associates
New York
+$3.65M
2
PRCM
Pine River Capital Management
Minnesota
+$317K
3
EIM
Essex Investment Management
Massachusetts
+$199K
4
Deutsche Bank
Deutsche Bank
Germany
+$164K
5
UCFA
United Capital Financial Advisors
Texas
+$131K

Top Sellers

Rank Fund Capital Flow
1
ACPU
Arrowgrass Capital Partners (US)
Delaware
-$4.39M
2
Two Sigma Investments
Two Sigma Investments
New York
-$197K
3
BCM
Bridgeway Capital Management
Texas
-$182K
4
Zurich Cantonal Bank
Zurich Cantonal Bank
Switzerland
-$150K
5
LCS
Levin Capital Strategies
New York
-$76.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
WRF
1
Waddell & Reed Financial
Kansas
$37.8M – – –
PWAM
2
Park West Asset Management
California
$6.85M – – –
RA
3
Royce & Associates
New York
$4.76M +$3.65M +400,746 +241%
ACPU
4
Arrowgrass Capital Partners (US)
Delaware
$3.91M -$4.39M -481,999 -51%
PRCM
5
Pine River Capital Management
Minnesota
$2.76M +$317K +34,817 +12%
LCS
6
Levin Capital Strategies
New York
$2.53M -$76.9K -8,447 -3%
Deutsche Bank
7
Deutsche Bank
Germany
$1.01M +$164K +18,000 +18%
BIT
8
BlackRock Institutional Trust
California
$925K +$71.7K +7,882 +8%
EIM
9
Essex Investment Management
Massachusetts
$493K +$199K +21,870 +59%
CS
10
Credit Suisse
Switzerland
$431K -$32.6K -3,584 -7%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$388K -$68.8K -7,560 -14%
Vanguard Group
12
Vanguard Group
Pennsylvania
$282K +$26.4K +2,900 +9%
NIMI
13
Natixis Investment Managers International
France
$268K – – –
Wells Fargo
14
Wells Fargo
California
$252K +$72.5K +7,966 +36%
Northern Trust
15
Northern Trust
Illinois
$168K +$67K +7,361 +58%
Goldman Sachs
16
Goldman Sachs
New York
$122K -$57.9K -6,359 -30%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$122K – – –
UCFA
18
United Capital Financial Advisors
Texas
$121K +$131K +14,365 New
BCM
19
Bridgeway Capital Management
Texas
$96K -$182K -20,000 -64%
Susquehanna International Group
20
Susquehanna International Group
Pennsylvania
$90K +$97.1K +10,668 New
Morgan Stanley
21
Morgan Stanley
New York
$85K +$910 +100 +1%
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$81K +$10.2K +1,124 +13%
Toronto Dominion Bank
23
Toronto Dominion Bank
Ontario, Canada
$42K +$22.2K +2,438 +95%
LTFS
24
Ladenburg Thalmann Financial Services
Florida
$26K +$28.2K +3,100 New
UBS Group
25
UBS Group
Switzerland
$22K +$23.8K +2,615 New
1
2

BIOA Hedge Fund Activity: Q4 2014 in Review

33 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in BioAmber Inc. (BIOA) for Q4 2014, worth a combined $63.7M — down 16% from $76M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new BIOA positions and 2 closed out — a net gain of 6 holders — while 12 added to existing stakes and 7 trimmed.

The largest buyer was Royce & Associates, adding an estimated $3.65M. The largest seller was Arrowgrass Capital Partners (US), cutting an estimated $4.39M.

  • 33 institutional investors held BioAmber Inc. (BIOA) as of Q4 2014, up from 27 in Q3 2014.
  • Funds reported $63.7M of BioAmber Inc. stock for Q4 2014, down 16% quarter-over-quarter.
  • 8 funds opened new BioAmber Inc. positions in Q4 2014 and 2 closed out, a net change of +6 holders.
  • The largest BioAmber Inc. buyer in Q4 2014 was Royce & Associates, an estimated $3.65M added.
  • The largest BioAmber Inc. seller in Q4 2014 was Arrowgrass Capital Partners (US), an estimated $4.39M sold.

Based on aggregated 13F filings for Q4 2014.